European equities traded in the US as American depositary receipts were tracking modestly higher late Monday morning, rising 0.33% to 1,919.10 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which rose 5.3% and 5% respectively. They were followed by biotech firm Evaxion (EVAX) and telecommunications company Ericsson (ERIC), which were up 3.7% and 2.4% respectively.
The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and pharmaceutical company Novo Nordisk (NVO), which fell 3% and 2.8% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and consumer goods company Unilever (UL), which were down 2.3% and 2.2% respectively.
The gainers from the UK were led by biopharmaceutical company NuCana (NCNA) and communications company WPP (WPP), which advanced 4.4% and 2.4% respectively. They were followed by lenders Barclays (BCS) and HSBC (HSBC), which increased 1.5% and 1.4% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company AstraZeneca (AZN) and software firm Endava (DAVA), which lost 4% and 3.7% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which dropped 3.6% and 2.9% respectively.
Comments